Sarafem: Effective Relief for Premenstrual Dysphoric Disorder

Product dosage: 10mg
Package (num)Per pillPriceBuy
60$0.67$40.16 (0%)🛒 Add to cart
90$0.62$60.24 $56.23 (7%)🛒 Add to cart
180$0.57$120.49 $102.41 (15%)🛒 Add to cart
270$0.55$180.73 $147.60 (18%)🛒 Add to cart
360
$0.54 Best per pill
$240.98 $193.78 (20%)🛒 Add to cart
Product dosage: 20mg
Package (num)Per pillPriceBuy
30$1.37$41.17 (0%)🛒 Add to cart
60$1.20$82.33 $72.29 (12%)🛒 Add to cart
90$1.16$123.50 $104.42 (15%)🛒 Add to cart
120$1.13$164.67 $135.55 (18%)🛒 Add to cart
180$1.10$247.00 $198.80 (20%)🛒 Add to cart
270$1.09$370.50 $293.19 (21%)🛒 Add to cart
360
$1.08 Best per pill
$494.00 $388.57 (21%)🛒 Add to cart
Synonyms

Similar products

Sarafem is a prescription medication specifically formulated to treat the emotional and physical symptoms of Premenstrual Dysphoric Disorder (PMDD). As a selective serotonin reuptake inhibitor (SSRI), it works by restoring the balance of serotonin in the brain, a key neurotransmitter involved in mood regulation. Clinically proven and FDA-approved, Sarafem offers a targeted approach to managing severe premenstrual symptoms, helping patients regain control over their emotional well-being and daily functioning. This medication is intended for use under the guidance of a healthcare provider and is part of a comprehensive treatment plan that may include lifestyle adjustments and therapy.

Features

  • Contains fluoxetine hydrochloride, the same active ingredient as Prozac, but packaged and dosed for PMDD
  • Available in 10 mg and 20 mg oral capsules
  • Typically taken once daily, with or without food
  • Begins to alleviate symptoms within the first treatment cycle for many patients
  • Manufactured under strict quality control standards

Benefits

  • Reduces severe irritability, tension, and mood swings associated with PMDD
  • Helps decrease feelings of sadness or hopelessness in the luteal phase
  • Can lessen physical symptoms such as bloating and breast tenderness
  • Improves overall daily functioning and interpersonal relationships
  • Supports a more predictable and manageable menstrual cycle experience
  • Non-habit forming with appropriate use under medical supervision

Common use

Sarafem is primarily prescribed for the treatment of Premenstrual Dysphoric Disorder (PMDD), a severe form of premenstrual syndrome that significantly interferes with daily life. It may also be used off-label for other conditions as determined by a healthcare provider, such as certain anxiety disorders or other mood-related manifestations. Patients typically begin treatment 14 days before the anticipated start of menstruation and continue through the first full day of menses, though dosing schedules may vary based on individual response and provider recommendation.

Dosage and direction

The recommended starting dosage of Sarafem is 20 mg taken orally once daily, either continuously throughout the menstrual cycle or limited to the luteal phase (typically the 14 days preceding menstruation). Your healthcare provider may adjust the dosage based on therapeutic response and tolerability, with a maximum recommended dose of 80 mg per day. Capsules should be swallowed whole with water and may be taken with or without food. It is important to follow the specific dosing instructions provided by your physician, as timing and duration of treatment may vary individually.

Precautions

Before taking Sarafem, inform your healthcare provider about any history of bipolar disorder, seizures, liver problems, or bleeding disorders. Use caution when operating machinery or driving until you know how Sarafem affects you, as it may cause dizziness or drowsiness. Avoid alcohol consumption while taking this medication, as it may worsen certain side effects. Regular monitoring may be necessary, particularly during the initial weeks of treatment or following dosage adjustments. Sarafem may increase the risk of bleeding; notify your provider if you experience unusual bruising or bleeding.

Contraindications

Sarafem is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to the risk of serotonin syndrome. It should not be used in combination with pimozide or thioridazine. Sarafem is contraindicated in patients with known hypersensitivity to fluoxetine hydrochloride or any component of the formulation. Use is not recommended during pregnancy unless clearly necessary and under close medical supervision, particularly during the third trimester.

Possible side effects

Common side effects may include headache, nausea, insomnia, fatigue, and dry mouth. Some patients may experience decreased libido, delayed orgasm, or other sexual dysfunction. Less frequently, Sarafem may cause anxiety, nervousness, sweating, or indigestion. Serious side effects requiring immediate medical attention include unusual changes in mood or behavior, suicidal thoughts, seizures, allergic reactions, or symptoms of serotonin syndrome (agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea).

Drug interaction

Sarafem may interact with numerous medications including other antidepressants, NSAIDs, anticoagulants, anticonvulsants, and certain migraine medications. It may increase levels of drugs metabolized by CYP2D6 enzymes, such as tricyclic antidepressants, antipsychotics, and some beta-blockers. Concurrent use with other serotonergic drugs increases the risk of serotonin syndrome. Always inform your healthcare provider of all medications, supplements, and herbal products you are taking before starting Sarafem.

Missed dose

If you miss a dose of Sarafem, take it as soon as you remember unless it is close to the time for your next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for a missed one. If you are on the luteal-phase dosing regimen and miss multiple doses, contact your healthcare provider for guidance on how to proceed with your treatment cycle.

Overdose

Symptoms of Sarafem overdose may include nausea, vomiting, agitation, restlessness, hypomania, and other signs of serotonin syndrome. In severe cases, seizures, coma, or cardiac arrhythmias may occur. If overdose is suspected, seek immediate medical attention or contact a poison control center. Treatment is supportive and may include activated charcoal, gastric lavage, and monitoring of vital signs. There is no specific antidote for fluoxetine overdose.

Storage

Store Sarafem capsules at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container, tightly closed, and away from light, moisture, and heat. Do not store in the bathroom. Keep all medications out of reach of children and pets. Properly dispose of any expired or unused medication according to FDA guidelines or through a medicine take-back program.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Sarafem is a prescription medication that should be used only under the supervision of a qualified healthcare provider. Individual results may vary, and not all patients will experience the same benefits or side effects. Always follow your healthcare provider’s instructions regarding dosage, administration, and duration of treatment. Do not start, stop, or change your dosage without consulting your physician.

Reviews

Clinical studies have demonstrated Sarafem’s effectiveness in reducing the symptoms of PMDD, with many patients reporting significant improvement in mood-related symptoms and overall quality of life. Patients often note decreased irritability, reduced mood swings, and improved ability to manage daily activities during the luteal phase. Some users report side effects such as initial nausea or sleep disturbances that often diminish with continued use. Healthcare providers generally consider Sarafem a valuable option in the management of severe PMDD when used as part of a comprehensive treatment approach.